Baqsimi ® (glucagon) nasal powder

3mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

How to position an unconscious person following administration of Baqsimi™ (glucagon) nasal powder?

It is recommended to turn the person on their side after administering Baqsimi (glucagon) nasal powder.

US_cFAQ_NG059_POSITION_AFTER_ADMINISTRATION
US_cFAQ_NG059_POSITION_AFTER_ADMINISTRATION
en-US

Postadministration Position

If the person is unconscious, it is recommended to turn the person on their side after administering the dose of Baqsimi.1

Reference

1Baqsimi [instructions for use]. Indianapolis, IN: Eli Lilly and Company; 2019.

Date of Last Review: January 14, 2022


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical